Abvc Biopharma (ABVC) Total Debt (2010 - 2026)
Abvc Biopharma (ABVC) recorded Total Debt of $59,462 in Q2 2026, down 93.2% from $871,951 a year earlier and down 33.0% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Total Debt (2010 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma reported Total Debt of $755,512, down 10.1% from FY2024.
- Annual Total Debt has declined for three straight years, with a five-year compound annual growth rate of -15.5% (FY2020 to FY2025).
- Across earlier years, Total Debt came in at $840,252 in FY2024 (-6.6%), $899,250 in FY2023 (-52.5%), $1.89 million in FY2022 (+15.5%) and $1.64 million in FY2021 (-6.5%).
- The Q2 2026 figure is the lowest quarterly Total Debt since Q4 2015.
- On a year-over-year basis, Total Debt has declined for seven consecutive quarters, with an average decline of 27.4% over the last eight quarters.
- Peak year-over-year performance for Total Debt in the last five years was growth of 15.5% in Q4 2022, against a decline of 93.2% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $88,737 (Q1 2026), $755,512 (Q4 2025) and $809,103 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | 59,462.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59,462.00 |
| Mar 31, 2026 | 88,737.00 |
| Dec 31, 2025 | 755,512.00 |
| Sep 30, 2025 | 809,103.00 |
| Jun 30, 2025 | 871,951.00 |
| Mar 31, 2025 | 801,407.00 |
| Dec 31, 2024 | 840,252.00 |
| Sep 30, 2024 | 896,250.00 |
| Jun 30, 2024 | 956,880.00 |
| Mar 31, 2024 | 860,750.00 |
| Dec 31, 2023 | 899,250.00 |
| Sep 30, 2023 | 852,500.00 |
| Jun 30, 2023 | 882,750.00 |
| Mar 31, 2023 | 902,000.00 |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.74 Mn |
API Access
Abvc Biopharma Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();